Alzheimer; News from the web:
PJ Pillows, creates lasting memories for both caregivers and their loved ones by making pillows personalized with images of family, friends and even pets.
Read all about it HERE
Get a great pillow
Navigation trouble could be a signal
Alzheimer; News from the web:
Researchers compared the navigation performance of 202 volunteers without genetic Alzheimer’s risk and 65 volunteers with increased genetic risk. The latter had a specific expression of the gene for apolipoprotein E, the APOE-ε4 allele.
Source:
Ruhr-Universitaet-Bochum
Journal reference:
Bierbrauer, A., et al. (2020) Unmasking selective path integration deficits in Alzheimer’s disease risk carriers. Science Advances. doi.org/10.1126/sciadv.aba1394.
Read all about it HERE
It’s good to be a woman
Alzheimer; News from the web:
Women with Alzheimer’s live longer than men with the disease, and scientists at UC San Francisco now have evidence from research in both humans and mice that this is because they have genetic protection from the ravages of the disease.
Read all about it HERE
Alzheimer’s drug for Autistic kids?
Alzheimer; News from the web:
An interesting development is that apparently an experimental drug, aimed to help people with Alzheimer’s, could play a role in helping children with certain types of Autims. Read the full story in our link for today.
Read all about it HERE
A better test for Alzheimer’s
Alzheimer; News from the web:
Clinical trials of Alzheimer’s medicines have failed frequently but now researchers believe that this may have been caused by the drugs given too late. So if they could just develop a test that would detect Alzheimer’s earlier, it would make the drugs that have failed for use later in the process, so much more productive.
Read all about it HERE
Delay Drug for Alzheimer’s moves closer
Alzheimer; News from the web:
The first drug shown to potentially delay the progression of Alzheimer’s disease could be approved next year.
The Food and Drug Administration (FDA) in the United States said that aducanumab had been accepted for a priority review process.
Read all about it HERE